Literature DB >> 208414

Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: value of measurement in diagnosis and treatment.

S R Bloom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 208414     DOI： 10.1007/bf01072425

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN： 0002-9211


× No keyword cloud information.
  12 in total

1.  Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia.

Authors:  J V VERNER; A B MORRISON
Journal:  Am J Med       Date:  1958-09       Impact factor: 4.965

2.  Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa.

Authors:  C J Schwartz; D V Kimberg; H E Sheerin; M Field; S I Said
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

3.  Endocrine pancreatic islet disease with diarrhea. Report of a case due to diffuse hyperplasia of nonbeta islet tissue with a review of 54 additional cases.

Authors:  J V Verner; A B Morrison
Journal:  Arch Intern Med       Date:  1974-03

4.  Vasoactive intestinal peptide and watery-diarrhoea syndrome.

Authors:  S R Bloom; J M Polak; A G Pearse
Journal:  Lancet       Date:  1973-07-07       Impact factor: 79.321

5.  Recognition and management of the diarrheal syndrome caused by nonbeta islet cell tumors of the pancreas.

Authors:  A R Kraft; R K Tompkins; R M Zollinger
Journal:  Am J Surg       Date:  1970-02       Impact factor: 2.565

6.  Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon.

Authors:  S I Said; V Mutt
Journal:  Eur J Biochem       Date:  1972-07-13

7.  Potent peripheral and splanchnic vasodilator peptide from normal gut.

Authors:  S I Said; V Mutt
Journal:  Nature       Date:  1970-02-28       Impact factor: 49.962

8.  Letter: Plasma-V.I.P. in ulcerative colitis.

Authors:  P D Fairclough; S R Bloom; S J Mitchell
Journal:  Lancet       Date:  1976-05-01       Impact factor: 79.321

9.  Letter: Vasoactive intestinal peptide in cirrhosis.

Authors:  E Elias; S J Mitchell; S R Bloom
Journal:  Lancet       Date:  1975-12-27       Impact factor: 79.321

10.  Watery diarrhoea and ganglioneuroma with secretion of vasoactive intestinal peptide.

Authors:  P G Swift; S R Bloom; F Harris
Journal:  Arch Dis Child       Date:  1975-11       Impact factor: 3.791
View more
  13 in total

Review 1.  Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.

Authors:  Zu-Yi Ma; Yuan-Feng Gong; Hong-Kai Zhuang; Zi-Xuan Zhou; Shan-Zhou Huang; Yi-Ping Zou; Bo-Wen Huang; Zhong-Hai Sun; Chuan-Zhao Zhang; Yun-Qiang Tang; Bao-Hua Hou
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

2.  A renal vipoma.

Authors:  I Hamilton; L Reis; S Bilimoria; R G Long
Journal:  Br Med J       Date:  1980-11-15

3.  Obstructive ileus of large bowel is associated with low tissue levels of neuropeptides in prestenotic bowel segment.

Authors:  R Prommegger; J Marksteiner; G Wetscher; J Tschmelitsch; U Eder; R Fischer-Colbrie; A Saria; E Bodner
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

4.  Effects of pancreatic polypeptide and vasoactive intestinal polypeptide on rat ileal and colonic water and electrolyte transport in vivo.

Authors:  Z C Wu; T M O'Dorisio; S Cataland; H S Mekhjian; T S Gaginella
Journal:  Dig Dis Sci       Date:  1979-08       Impact factor: 3.199

5.  Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndrome.

Authors:  S I Said
Journal:  World J Surg       Date:  1979-09-20       Impact factor: 3.352

6.  Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome.

Authors:  Olafur S Palsson; Olivier Morteau; Eugene M Bozymski; John T Woosley; R Balfour Sartor; Michael J Davies; David A Johnson; Marsha J Turner; William E Whitehead
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

7.  Giant metastatic VIPoma in the liver.

Authors:  K Dohmen; N Fukushima; T Fujisaki; R Iwakiri; Y Yamano; M Nagano; K Wada; K Kodama; Y Iwata; K Hachimine
Journal:  Gastroenterol Jpn       Date:  1991-08

8.  Effect of peptide histidine isoleucine on water and electrolyte transport in the human jejunum.

Authors:  K J Moriarty; J E Hegarty; K Tatemoto; V Mutt; N D Christofides; S R Bloom; J R Wood
Journal:  Gut       Date:  1984-06       Impact factor: 23.059

9.  A report of five patients with large-volume secretory diarrhea but no evidence of endocrine tumor or laxative abuse.

Authors:  N W Read; M G Read; G J Krejs; R S Hendler; G Davis; J S Fordtran
Journal:  Dig Dis Sci       Date:  1982-03       Impact factor: 3.199

10.  Release of vasoactive intestinal peptide in the dumping syndrome.

Authors:  G R Sagor; M G Bryant; M A Ghatei; R M Kirk; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.